×
CCL5 is associated with poor prognosis in locally advanced pancreatic cancer (LAPC): biomarker analysis from the randomised phase II SCALOP trial.
Willenbrock F., Cox C., Wilhelm-Benartzic C., Owens R., Sabbagh A., Abraham A., Maughan T., Hurt C., O'Neill E., Mukherjee S.
DOI
10.1093/annonc/mdz156.001
Type
Conference paper
Publication Date
07/2019
Volume
30 Suppl 4